To investigate whether targeting SLC45A2-AMACR is feasible in a spontaneous liver cancer model, we constructed an SLC45A2-AMACR cDNA with a full breakpoint intron to mimic the genome structure of SLC45A2-AMACR gene fusion. This evidence concerns the gene SLC45A2 and liver cancer.